REFERENCES
- Szeto CC, Li P, Johnson DW, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int 2017;37:141–54.
- Augmentin (package insert). Dr Reddys Laboratories Inc., September 2016. http://medlibrary.org/lib/rx/meds/augmentin-2/ Accessed May 31, 2017.
- Piraino B, Bernardini J, Brown E, et al. ISPD position statement on reducing the risks of peritoneal dialysis–related infections. Perit Dial Int 2011;31:614–30.
- Gardezi AI, Schlageter KW, Foster DM, et al. Erosion of the silicone peritoneal dialysis catheter with the use of gentamicin cream at the exit site. Advances in Peritoneal Dialysis 2016;32:15–18.
- Bernardini J, Bender F, Florio T, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005;16(2):539–45.
- Li P, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 2016:36:481–508.
- Li P, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010;30:393–423.
- Gerig JS, Bolton ND, Swabb EA, Scheld WM, Bolton WK. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics. Kidney Int 1984;25:308–18.
- Lupo A, Rugiu C, Bernich P, et al. A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: teicoplanin plus tobramycin versus cephalothin plus tobramycin. J Antimicrob Chemother 1997;40(5):729–32.
- Lam MF, Tang BS, Tse KC, Chan TM, Lai KN. Ampicillin-sulbactam and amikacin used as second-line antibiotics for patients with culture-negative peritonitis. Perit Dial Int 2008;28(5):540–2.
- Fish R, Nipah R, Jones C, Finney H, Fan SL. Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels. Perit Dial Int 2012;32(3):332–8.
